Persistence and Adherence during the First Six Months of Tocilizumab Treatment Among Rheumatoid Arthritis Patients in Routine Clinical Practice in Greece. Results from the Single Arm REMISSION II Study (NCT01649817)

OBJECTIVE/AIM: One of the most important factors that affect a treatment’s performance in rheumatoid arthritis (RA) is adherence to medications. According to literature, there are several reasons for non-adherence in RA patients with some of them being related to a specific patient profile of the st...

Descripción completa

Detalles Bibliográficos
Autores principales: Markatseli, Theodora E., Theodoridou, Athina, Zakalka, Marina, Koukli, Eftychia, Triantafyllidou, Eva, Tsalavos, Sotiris, Andrianakos, Alexandros, Drosos, Alexandros A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045860/
https://www.ncbi.nlm.nih.gov/pubmed/32185362
http://dx.doi.org/10.31138/mjr.30.3.177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045860/
https://www.ncbi.nlm.nih.gov/pubmed/32185362
http://dx.doi.org/10.31138/mjr.30.3.177

Ejemplares similares